Manufacturer of Smart Stable Hospital Use Insulin Needle-Free - TECHiJET QS-P (U100 Insulin Needle-free Injector) – Quinovare

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our company has been focusing on brand strategy. Customers' satisfaction is our best advertising. We also supply OEM service for Class 3 Needle-Free Device , Injector Pen , Hyaluronic Acid Hyaluron Pen Cross Linked , We've got professional products knowledge and rich experience on manufacturing. We generally imagine your success is our business enterprise!
Manufacturer of Smart Stable Hospital Use Insulin Needle-Free - TECHiJET QS-P (U100 Insulin Needle-free Injector) – Quinovare Detail:

Detail

The QS-P Needle-free Injector is design to inject subcutaneous medications such us insulin, human growth hormone, local anesthetic and vaccine. For now QS-P has been approved to inject Insulin and Human growth hormones in China. The QS-P Needle-free Injector is a spring powered device, it uses a high pressure to release liquid medication from a micro orifice to create an ultrafine liquid stream that instantly penetrates skin to the subcutaneous tissue.

The QS-P is the second generation needle free injector after QS-M, the concept of design is portable, and it is very easy to put in the pocket or small bag. Another concept of this design is light, the weight of QS-P is less than 100 grams. Quinovare hopes children or elderly can use it by themselves. Operations using QS-P injector are conveniently easy to follow; first charge the device, second extract medication and choose the dosage and third inject medication. This steps can be learn within 10 minutes. Other needle-free injector consist of two different parts, the injector and the pressure box (reset box or handling charger). As for QS-P it is an all in one design injector, so it is more convenient to use. The third concept of design is warmth, most of people feels cold or pain or afraid of needles, we tried our best to design our injector to looks warmth and doesn’t looks like an injector. We wanted that clients can use the injector comfortably and have a confidence every time they use it. Because of its features and design QS-P acquired the Good Design Award of 2016, Golden Pin Design Award of 2019 and Red Star Design Award of 2019.

QS-P was developed in 2014, we launched QS-P to the market last 2018 in China, its ampoule capacity is 0.35 ml and the dosage range is 0.04 to 0.35 ml. QS-P obtained the CFDA (China Food and Drug Association), CE mark and ISO13485 in 2017.

Steps

Family Scene

Business Scene


Product detail pictures:

Manufacturer of Smart Stable Hospital Use Insulin Needle-Free - TECHiJET QS-P (U100 Insulin Needle-free Injector) – Quinovare detail pictures

Manufacturer of Smart Stable Hospital Use Insulin Needle-Free - TECHiJET QS-P (U100 Insulin Needle-free Injector) – Quinovare detail pictures

Manufacturer of Smart Stable Hospital Use Insulin Needle-Free - TECHiJET QS-P (U100 Insulin Needle-free Injector) – Quinovare detail pictures


Related Product Guide:

Our target is always to satisfy our customers by offering golden support, superior value and high quality for Manufacturer of Smart Stable Hospital Use Insulin Needle-Free - TECHiJET QS-P (U100 Insulin Needle-free Injector) – Quinovare , The product will supply to all over the world, such as: Milan, Israel, moldova, Our domestic website's generated over 50, 000 purchasing orders every year and quite successful for internet shopping in Japan. We would be happy to have an opportunity to do business with your company. Looking forward to receiving your message !
  • The company keeps to the operation concept "scientific management, high quality and efficiency primacy, customer supreme", we have always maintained business cooperation. Work with you,we feel easy!
    5 Stars By Astrid from Chile - 2018.02.08 16:45
    The sales manager is very patient, we communicated about three days before we decided to cooperate, finally, we are very satisfied with this cooperation!
    5 Stars By Lee from Salt Lake City - 2017.09.22 11:32
    Write your message here and send it to us